CINECA IRIS Institutional Research Information System

The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical managements of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.

Antibodies against Human Cytomegalovirus (HCMV)

FUNARO, Ada;GRIBAUDO, Giorgio;LANDOLFO, Santo Giuseppe
2008-01-01

Abstract

The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical managements of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
2008
WO 2008/071806 A1
Ribovax Biotechnologies SA
http://www.wipo.int/pctdb/en/ia.jsp?ia=EP2007/064094
human monoclonal antibodies; human cytomegalovirus infection; neutralizing antibodies
FUNARO A; GRIBAUDO G; LANDOLFO S
06A-Brevetto
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/34952
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact